BloG

Here finds you our updates from our reporter Dolly.
Prophylactic treatment with antagonistic anti-TNFα antibodies may improve outcomes of anti-PD-1 and anti-CTLA-4 combination cancer immunotherapy

Prophylactic treatment with antagonistic anti-TNFα antibodies may improve outcomes of anti-PD-1 and anti-CTLA-4 combination cancer immunotherapy

The combination of anti-PD-1 and anti-CTLA-4 antibody-mediated immunotherapy is remarkably effective against melanoma, renal cell carcinoma, and non-small-cell lung cancer. However, this comes at the cost of frequent, serious immune-related adverse events. Colitis is...

read more
Immune Checkpoints and Co-stimulators

Immune Checkpoints and Co-stimulators

Facilitate Your Immune Regulations StudyThe recognition of the antigenic peptide-MHC I/II complex on antigen presenting cells (APCs) through the T cell receptor (TCR) initiates T cell-mediated immunity. However, the interaction of antigen-MHC complexes with the TCR is...

read more

JOIN OUR NEWSLETTER!